Quick Answer
Pumpkin Seed Oil Bone Health Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: CKD is recognized as an independent risk factor for cardiovascular morbidity even after adjustment for traditional cardiovascular risk factors, with the prevalence of cardiovascular disease being 75.3% in stage 4 CKD as compared to 37.5% in the non-CKD population [].
Key Takeaways
- 01CKD is recognized as an independent risk factor for cardiovascular morbidity even after adjustment for traditional cardiovascular risk factors, with the prevalence of cardiovascular disease being 75.3% in stage 4 CKD as compared to 37.5% in the non-CKD population []. [Lau Wei Ling (2026)]
- 02Non-traditional risk factors contributing to cardiovascular disease in CKD patients include disrupted mineral–bone metabolism, chronic inflammation and oxidative stress, a deficiency of inhibitors of vascular calcification inhibitors, and protein–energy wasting []. [Lau Wei Ling (2026)]
- 03There is growing evidence that metabolites from the gut microbiota promote this cardiovascular risk. [Lau Wei Ling (2026)]
- 041 2 3 1 4 4 5 6 Chronic kidney disease (CKD) is a global health issue leading to multi-organ complications including heightened cardiovascular morbidity. [Lau Wei Ling (2026)]
The current Migaku evidence database contains 2 reusable source documents for Pumpkin Seed Oil Bone Health Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts.
- CKD is recognized as an independent risk factor for cardiovascular morbidity even after adjustment for traditional cardiovascular risk factors, with the prevalence of cardiovascular disease being 75.3% in stage 4 CKD as compared to 37.5% in the non-CKD population []. [Lau Wei Ling (2026); evidence level 3]
- Non-traditional risk factors contributing to cardiovascular disease in CKD patients include disrupted mineral–bone metabolism, chronic inflammation and oxidative stress, a deficiency of inhibitors of vascular calcification inhibitors, and protein–energy wasting []. [Lau Wei Ling (2026); evidence level 3]
- There is growing evidence that metabolites from the gut microbiota promote this cardiovascular risk. [Lau Wei Ling (2026); evidence level 3]
- 1 2 3 1 4 4 5 6 Chronic kidney disease (CKD) is a global health issue leading to multi-organ complications including heightened cardiovascular morbidity. [Lau Wei Ling (2026); evidence level 3]
- Food fortification is a potentially effective approach because it provides necessary micronutrients, but it cannot replicate the nutritional profile and health advantages found in naturally nutrient‐rich foods (Kakkar et al. ). [Raza Nighat (2026); evidence level 3]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources